SCHEMBL5240366

SCHEMBL5240366

Brc1c[nH]c(C(c2ccccc2)(c2ccccc2)c2ccccc2)n1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 1/20 0.31
CCNE1 P24864 1/20 0.30
CDK2 P24941 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1484198 0.77 KCNN4 (0.31) KCNN4
SCHEMBL5738210 0.77 ADORA2A (0.32) KCNN4
SCHEMBL3827052 0.77 KCNN4 (0.33) KCNN4
SCHEMBL5286108 0.74 ALDH1A1 (0.40)
SCHEMBL8307156 0.73 ABCG2 (0.36)
SCHEMBL6411394 0.73 NOTUM (0.34) CDK2
SCHEMBL1828996 0.73 KDM4E (0.39)
SCHEMBL7802981 0.73 TSHR (0.30)
Hydrochloric Acid SCHEMBL9670896 0.72
SCHEMBL6958918 0.70 TDP1 (0.34) CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828152-A2 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF FACTOR VIIA Bristol-Myers Squibb Company (US) 2007-09-05 EP disclosed
WO-2006062972-A2 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF FACTOR VIIA BRISTOL-MYERS SQUIBB COMPANY (US) 2006-06-15 WO disclosed